Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interaction between amiodarone and lidocaine

H R Ha1, R Candinas, B Stieger

  • 1Cardiovascular Therapy Research Unit, University Hospital, Zurich, Switzerland.

Journal of Cardiovascular Pharmacology
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurements of the associated production of a W boson and a charm quark in proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2022
Same author

Using Z Boson Events to Study Parton-Medium Interactions in Pb-Pb Collisions.

Physical review letters·2022
Same author

Evidence for X(3872) in Pb-Pb Collisions and Studies of its Prompt Production at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2022
Same author

MUSiC: a model-unspecific search for new physics in proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2021
Same author

Measurements of angular distance and momentum ratio distributions in three-jet and <math></math> + two-jet final states in <math></math> collisions.

The European physical journal. C, Particles and fields·2021
Same author

Development and validation of HERWIG 7 tunes from CMS underlying-event measurements.

The European physical journal. C, Particles and fields·2021

Amiodarone and its metabolite N-monodesethylamiodarone inhibit lidocaine metabolism by affecting cytochrome P-450 3A4 (CYP3A4). This drug interaction increases lidocaine levels in the body, impacting cardiac patient treatment.

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Clinical Pharmacology

Background:

  • Amiodarone and lidocaine are commonly used antiarrhythmic drugs.
  • Understanding their potential drug interactions is crucial for patient safety.

Purpose of the Study:

  • To investigate the in vitro and in vivo interactions between amiodarone and lidocaine.
  • To elucidate the molecular mechanisms underlying this drug interaction.

Main Methods:

  • In vitro studies using human liver microsomes to assess enzyme kinetics.
  • In vivo pharmacokinetic study in cardiac patients receiving lidocaine before and during amiodarone treatment.

Main Results:

  • Amiodarone and its metabolite N-monodesethylamiodarone competitively inhibit CYP3A4-mediated metabolism of lidocaine.

Related Experiment Videos

  • In vivo, amiodarone administration increased lidocaine's area under the curve and decreased its systemic clearance.
  • The interaction was evident early in amiodarone loading, with no further changes during maintenance therapy.

    • Conclusions:

    • Amiodarone and its metabolite DEA significantly interact with lidocaine metabolism, primarily through CYP3A4 inhibition.
    • This interaction can lead to altered lidocaine pharmacokinetics, necessitating careful monitoring in patients receiving both drugs.